Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Riga Stradiņš University, LV-1007 Riga, Latvia.
Department of Pharmaceuticals, Red Cross Medical College of Riga Stradiņš University, LV-1009 Riga, Latvia.
Medicina (Kaunas). 2023 Jul 21;59(7):1339. doi: 10.3390/medicina59071339.
: Direct oral anticoagulants (DOACs) are used for minimising the risk of thromboembolic events. In clinical practice, there is no need to measure DOAC concentration in the routine. Nevertheless, there are cases where such measurements are necessary, as the European Society of Cardiology's guideline recommends. However, determining DOAC levels is not available for everyone due to chromogenic assay availability limitations from sample storage problems, as tests are performed only in a few healthcare settings. This study aimed to assess whether more applicable storage conditions could be used for transportation to provide chromogenic assays for outpatient healthcare and other hospitals' practices. : Chromogenic assays measuring anti-FXa (for rivaroxaban and edoxaban) and anti-FIIa (for dabigatran) were used. Concentrations were determined immediately after blood collection as baseline value: (1) after the storage of citrated whole blood in refrigerator (+2-8 °C); (2) of citrated plasma in refrigerator (+2-8 °C); and (3) of citrated frozen plasma (-20 °C) on the third and seventh days of storage. Acceptable change limits were considered stable if the deviation did not exceed ±20% of the baseline value. : The median (Cl 95%) baseline value of rivaroxaban was 168 (147-236) ng/mL; of dabigatran 139 (99-178) ng/mL; and of edoxaban-174 (135-259) ng/mL. The median deviation from a baseline value stored as citrate whole blood samples (+2-8 °C) was 5.4% and 3.4%; as citrated plasma (+2-8 °C) was 0.4% and -0.6%; and as citrated frozen plasma (-20 °C) was -0.2% and 0.2% on the third and seventh days of storage, respectively. : Our data suggest that whole blood samples stored in a refrigerator, as well as citrated plasma samples stored in both the refrigerator and freezer, preserve DOAC concentration stable at +2-8 °C or -20 °C for up to 7 days, and are suitable for transportation, except for low-concentration samples.
直接口服抗凝剂(DOACs)用于降低血栓栓塞事件的风险。在临床实践中,没有必要常规测量 DOAC 浓度。然而,欧洲心脏病学会的指南建议,在某些情况下需要进行这种测量。然而,由于显色测定法受到样本储存问题的限制,并非每个人都能进行 DOAC 水平的测定,因为这些测试仅在少数医疗保健环境中进行。本研究旨在评估是否可以使用更适用的储存条件进行运输,以便为门诊医疗保健和其他医院的实践提供显色测定法。
使用测量抗 FXa(用于利伐沙班和依度沙班)和抗 FIIa(用于达比加群)的显色测定法。在采血后立即测定浓度作为基线值:(1)在冰箱(+2-8°C)中储存枸橼酸盐全血;(2)在冰箱(+2-8°C)中储存枸橼酸盐血浆;(3)在冰箱(-20°C)中储存枸橼酸盐冰冻血浆,分别在第 3 天和第 7 天储存。如果偏差不超过基线值的±20%,则认为可接受的变化范围是稳定的。
利伐沙班的中位(95%CI)基线值为 168(147-236)ng/mL;达比加群为 139(99-178)ng/mL;依度沙班为 174(135-259)ng/mL。与枸橼酸盐全血样本(+2-8°C)相比,第 3 天和第 7 天储存时的中位数偏差分别为 5.4%和 3.4%;与枸橼酸盐血浆(+2-8°C)相比,中位数偏差分别为 0.4%和-0.6%;与枸橼酸盐冰冻血浆(-20°C)相比,中位数偏差分别为-0.2%和 0.2%。
我们的数据表明,在冰箱中储存的全血样本,以及在冰箱和冷冻室中储存的枸橼酸盐血浆样本,在+2-8°C 或-20°C 下储存长达 7 天,DOAC 浓度保持稳定,适合运输,但低浓度样本除外。